CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status
Significance of ER-Src axis in hormonal therapy resistance
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase
P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis
Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance
Struggling with subtypes: trying to bridge the gap between molecular breast cancer subtypes and clinical management
A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients
Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study
IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR
Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy
A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments
Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype
Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society
Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case-control study
Unmet supportive care needs: a cross-cultural comparison between Hong Kong Chinese and German Caucasian women with breast cancer
Effect of false-positives and women's characteristics on long-term adherence to breast cancer screening
Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden
Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis
Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy
Long-term course of pain in breast cancer survivors: a 4-year longitudinal study
Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger
Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups
Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses
Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care
Correlation between docetaxel-induced skin toxicity and the use of steroids and H2 blockers: a multi-institution survey
Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity
CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin
Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR - 34a microRNA
Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer
What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?
Predicting lymphatic drainage patterns and primary tumour location in patients with breast cancer
Anti-cytokeratin CAM 5.2 (B.D. Biosciences) has a primary reactivity with CK 7 and CK 8 (48 and 52 kD) rather than with the smaller molecular weight keratin breakdown fractions (50, 43, and 38 kD)
A Halsted mastectomy 21 years before Halsted